Heart failure with preserved and reduced ejection fraction: different phenotypes in old-elderly patients?

Eur J Intern Med. 2013 Jun;24(4):346-8. doi: 10.1016/j.ejim.2013.01.018. Epub 2013 Feb 20.

Abstract

Background: Patients with heart failure with preserved ejection fraction (HFPEF) represent an important group of patients presenting in clinical practice. However, whether it is an earlier stage of heart failure with reduced ejection fraction (HFREF) remains uncertain. We evaluated the potential progression of HFPEF to HFREF.

Methods and results: We evaluated retrospectively 178 patients (mean age 80.5±5.8 years; 75.3% females) with heart failure with preserved ejection fraction from a specialized Internal Medicine unit, offering an integrated usual care. Diagnosis of heart failure with preserved ejection fraction was made according to European guidelines. The main objective was to evaluate the progression to systolic dysfunction, defined by left ventricular ejection fraction less than 45%. Mean baseline left ventricular ejection fraction was 64.6±7.2. After a mean follow-up of 24-months, mean baseline ejection fraction was 67.1±9.3%. Only five patients (2.8%) progressed to HFREF. Brain natriuretic peptide values were significantly higher in those patients who progressed.

Conclusions: These results strongly suggest that heart failure with preserved and reduced ejection fraction could be distinct pathophysiological entities, at least in elderly patients.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Disease Progression
  • Echocardiography
  • Female
  • Follow-Up Studies
  • Heart Failure / classification
  • Heart Failure / diagnosis
  • Heart Failure / physiopathology*
  • Humans
  • Male
  • Natriuretic Peptides / blood*
  • Phenotype
  • Stroke Volume / physiology*
  • Ventricular Dysfunction / diagnosis*
  • Ventricular Dysfunction / physiopathology

Substances

  • Natriuretic Peptides